Pharmacokinetics, Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 2 Years of Age

Pharmacokinetics, Safety and Pharmacodynamics After Multiple Oral Doses of Dabigatran Etexilate Capsule in Healthy Japanese and Caucasian Male Subjects

NCT02171468 ·Status: COMPLETED ·Phase: PHASE1

Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTE

NCT00558259 ·Status: COMPLETED ·Phase: PHASE3

Phase 1 Pediatric Pharmacokinetics/Pharmacodynamics (PK/PD) Study

NCT02303431 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate in Patients With and Without Renal Impairment

NCT02182024 ·Status: COMPLETED ·Phase: PHASE1

EINSTEIN Junior Phase II: Oral Rivaroxaban in Young Children With Venous Thrombosis

NCT02309411 ·Status: COMPLETED ·Phase: PHASE2

Rivaroxaban for Intracardiac Thrombosis in the Pediatric Population

NCT06371170 ·Status: RECRUITING

A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolism (VTE)

NCT05900388 ·Status: NOT_YET_RECRUITING

Randomized, Open Label Study of Dabigatran Etexilate in Elective Percutaneous Coronary Intervention

NCT00818753 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism

NCT00291330 ·Status: COMPLETED ·Phase: PHASE3

Assessment of Electrophysiological Effects of Dabigatran Etexilate as Single Dose on the QT Interval in Healthy Female and Male Subjects.

NCT02170987 ·Status: COMPLETED ·Phase: PHASE1

Use of Dabigatran Etexilate to Prevent Stroke and Thromboembolism

NCT01976507 ·Status: COMPLETED ·Phase: PHASE4

Multiple-Dose Study Apixaban in Pediatric Subjects With an Indwelling Central Venous Catheter

NCT01195727 ·Status: TERMINATED ·Phase: PHASE1

Oral Rivaroxaban in Children With Venous Thrombosis

NCT01684423 ·Status: COMPLETED ·Phase: PHASE2

Relative Bioavailability and Pharmacodynamics of Dabigatran With Enoxaparin in Healthy Male and Female Volunteers

NCT02171559 ·Status: COMPLETED ·Phase: PHASE1

Reversal Dabigatran Anticoagulant Effect With Idarucizumab

NCT02815670 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate a Single Dose of Apixaban in Pediatric Participants at Risk for a Thrombotic Disorder

NCT01707394 ·Status: COMPLETED ·Phase: PHASE1

The Efficacy and Safety of Dabigatran Etexilate for the Treatment of Cerebral Venous Thrombosis

NCT03217448 ·Status: UNKNOWN ·Phase: PHASE3

Management of Major Bleeding Events in Atrial Fibrillation Patients Using Pradaxa

NCT02149303 ·Status: COMPLETED

Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE)

NCT00680186 ·Status: COMPLETED ·Phase: PHASE3

Oral Anticoagulant Apixaban for Treatment of Venous Thromboembolism

NCT04041843 ·Status: COMPLETED ·Phase: PHASE2

Safety and Pharmacokinetics of Quinidine Alone and in Combination With Dabigatran Etexilate

NCT02171624 ·Status: COMPLETED ·Phase: PHASE1

An Observational Study to Learn More About How Safe Treatment With Rivaroxaban is in Children in Japan With Venous Thromboembolism

NCT06278051 ·Status: COMPLETED

Study of PF-04965842 Effect on Dabigatran Pharmacokinetics in Healthy Participants

NCT03742336 ·Status: COMPLETED ·Phase: PHASE1

Low Molecular Weight Heparin for 72 Hours Followed by Dabigatran for Acute Intermediate-Risk Pulmonary Embolism.

NCT02596555 ·Status: TERMINATED ·Phase: PHASE4

Secondary Prevention of Venous Thrombo Embolism (VTE).

NCT00329238 ·Status: COMPLETED ·Phase: PHASE3